| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |